BioSpace News Archive

Amgen announced the opening of a new research and development site in San Francisco’s Oyster Point, continuing the company’s nearly two-decade presence in the region.

CHS USA Inc., a company of Canadian Hospital Specialties Limited, completed the acquisition of Medical Imaging Solutions International., effective September 16th, 2022.

CurvaFix, Inc. announced participation in the Industry Sessions of the Orthopaedic Trauma Association 38th Annual Meeting, Oct. 12-15 in Tampa, Fl, highlighting the expanding use of the CurvaFix® IM Implant by industry-leading surgeons for both fragility and high-impact fractures of the pelvis.

Epic Bio, a biotechnology company developing therapies to modulate gene expression using the compact, non-cutting dCasMINI protein, announced that the company will be participating in the Solebury / BMO Fall Private Company Showcase, taking place Thursday, October 13, 2022, in New York.

Owlet, Inc. (NYSE: OWLT) (the “Company”) announces that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (“FDA”) for a new prescription monitoring device for infants.

Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Corporation”), a drug discovery company aimed at developing therapeutics that regenerate muscle as a new approach to treating disease conditions from muscular dystrophy to aging, is pleased to announce that its common shares have commenced trading on the OTCQB Venture Market (“OTCQB”) under the symbol “MSCLF”.

Genetesis, the market leader in next-generation biomagnetic imaging, has announced that it has closed $17.5 million in Series C Financing.

Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has been granted US patent 11,400,145, entitled “Genetically modified cells and uses thereof”.

CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, has been awarded a $3 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH).

The latest market analysis report published by Reports and Data, titled ‘Global Bone Resorption Treatment Market – Forecast to 2030,’ thoroughly examines the Bone Resorption Treatment industry to provide essential data & information for the targeted readers.